Hosted on MSN

Harmony’s cannabidiol drug flops in pivotal Fragile X Syndrome trial

Harmony Biosciences’ transdermal cannabidiol ZYN002 suffered a setback as a Phase III trial failed to meet the primary endpoint in a Fragile X Syndrome trial, with the biotech blaming a ...
Gizmochina

Huawei’s humanoid robot in testing at EV marker Nio’s factory

Chinese electric vehicle (EV) manufacturer Nio is reportedly exploring the potential of humanoid robots in its production lines. A recent report by China Star Market revealed that Nio is testing the ...
Reuters

Huawei's Harmony aims to end China's reliance on Windows, Android

OpenHarmony open-source operating system being championed in China HarmonyOS overtakes Apple's iOS in popularity on Chinese smartphones Western operating systems face loss of market share -analyst ...
The Business Journals

Harmony Biosciences shares plummet as drug fails in late-stage trial

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Harmony Biosciences faces a ...